Similarly, Miller et al. reported BAY-876, a high-affinity GLUT1 inhibitor (IC50 ≈ 2 nM), which potently suppresses glucose uptake and cellular viability in head and neck squamous cell carcinoma (HNSCC) cells [31]. The gene discussed is SLC2A1; the disease is head and neck squamous cell carcinoma.